Creating a defect in tRNA molecules could weaken bacteria’s two-pronged defense and help make faster-acting antibiotics
Antibiotic resistance is a major health threat, with about two million people in the U.S. getting an antibiotic-resistant infection per year, according to the Centers for Disease Control and Prevention (CDC). Gram negative bacteria, including types like E.coli and Salmonella, are often more difficult to kill because of their two-pronged defenses – they have two membranes rather than one, and also have numerous toxin pumps embedded in the membranes to expel any antibiotic that may have made it through. Now Jefferson researchers have uncovered how to target both of these defenses with one hit, which could help make antibiotics more effective.
“We showed that interfering with a transfer RNA (tRNA) molecule, in a way that is unique to bacteria, cripples the bacterial cell’s ability to make membrane proteins required for the drug barrier and efflux activity,” says senior author Ya-Ming Hou, PhD, Professor of Biochemistry at the Sidney Kimmel Medical College at Jefferson (Philadelphia University + Thomas Jefferson University). The work was published in the journal Cell Systems.
tRNA molecules are not a typical antibiotic target. These molecules are part of the protein-building machinery that is essential for the daily function of cells in every living being. However, Dr. Hou’s team examined a kind of chemical “decoration” process in bacterial tRNAs that is absent from human cells. This difference between bacteria and humans makes this process a better drug target, since it’s less likely affect human cells.
tRNAs are decorated with chemical groups that are added on after tRNAs are synthesized in a cell. Dr. Hou’s group examined one such decoration, the addition of a methyl group to one particular location on the spine of several tRNAs. In earlier work, Dr. Hou’s lab showed that when these tRNAs were deficient in this one methylation, they were more likely to create errors in protein building. But not just any protein, the deficient tRNAs were particularly prone to mistakes at building proteins that sit within cell membrane.
This result made Dr. Hou think that perhaps a defect in the tRNA methylation might affect not only the bacteria’s toxin-pump, but a host of other types of proteins that help keep the membrane stable and cohesive.
In this paper, together with first author postdoctoral fellow Isao Masuda and others, Dr. Hou tested whether these defective tRNAs could make bacteria more susceptible to antibiotics, by creating bacteria that are genetically deficient in making the methyl-group decoration.
Through an elegant series of experiments, Dr. Hou’s team showed that these bacteria had membranes that were less cohesive and more permeable than normal. The bacteria with defective tRNAs were less effective at pumping out chemicals relative to the normal bacteria, suggesting that their toxin pumps were affected. Finally, the team showed that when the bacteria with defective tRNAs were exposed to various antibiotics, they died faster and were also less capable of developing drug resistance.
“Speed of killing is important in antibiotics,” says Dr. Hou. “The longer it takes for bacteria to die from antibiotics, the more likely they are to develop resistance.”
While pharmaceutical companies such as AstraZeneca and GSK have discovered compounds that can inhibit the enzyme from making the critical methylation on tRNAs, progress has stalled. The primary reason is that the inhibitors are unable to permeate through the bacterial membrane structure, which resonates with the major challenge confronting the entire field of antibiotic discovery.
Dr. Hou acknowledges the challenge. “First, we need to formulate the inhibitors in such a way as to be able to enter the cell more effectively,” says Dr. Hou. “Then, combining these inhibitors with traditional antibiotics to kill bacteria faster and reduce the likelihood of antibiotic resistance.”
At the moment, there are no drugs that can effectively attack this pathway. Dr. Hou’s lab is currently working on developing better inhibitors.
Learn more: Breaking Open the Gates of Antibiotic Resistance
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure on May 21, 2019 at 6:06 am
Antimicrobial resistance (AMR) is one of the latest issues to galvanise political and financial investment as an emerging global health threat. This paper explores the construction of AMR as a problem ... […]
- Preventing Antibiotic Resistance: Look to the Livestock Industry on May 21, 2019 at 4:57 am
UNITED NATIONS, May 21 2019 (IPS) - Antimicrobial resistance is quickly becoming a global crisis and risks reversing a century of progress in health. Some organisations have already geared up and are ... […]
- 'It's not going away': WSU researchers warn of antibiotic resistance on May 21, 2019 at 2:10 am
SPOKANE, Wash. — A group of researchers at Washington State University are studying bacteria that can't be stopped with antibiotics, in hopes of solving a worldwide problem. Hospitals are starting to ... […]
- Wound dressing uses electricity to bust up antibiotic-resistant bacterial infections on May 20, 2019 at 7:18 pm
Offering a novel way to battle antibiotic resistant infections, the dressing has been approved by the FDA and is currently being tested in human burn patients. The National Institutes of Health ... […]
- Strengthening antibiotics against resistant bacteria on May 20, 2019 at 1:06 pm
At least 2 million Americans will develop an antibiotic-resistant infection this year. Drugs that used to work, like penicillin or amoxicillin, often don't anymore. These resistant infections are on ... […]
- What The Health?! Oilers' owner's life-threatening illness is a scary reminder of antibiotic resistance on May 17, 2019 at 1:53 pm
After the Edmonton Oilers’ billionaire owner recently made a rare appearance at a press conference to announce the hiring of the team’s new general manager, Daryl Katz became news himself. It turns ... […]
- AI-powered 'knowledge engine' a game-changer for antibiotic resistance on May 17, 2019 at 6:11 am
A groundbreaking project to tackle one of the world's most pressing and complex health challenges—antimicrobial resistance (AMR)—has secured a $1 million boost. UTS will lead a consortium of ... […]
- Animal agriculture is not the cause of antibiotic resistance on May 16, 2019 at 10:09 am
There’s no arguing that antimicrobial resistance is a concern and something to be cognizant about. The ability to treat a wide range of diseases and illnesses is an extremely valuable tool that we ... […]
- LexaGene Completes Development of Antibiotic Resistance Panel on May 15, 2019 at 5:58 am
Adds capability to detect antibiotic resistance in pathogens within just one hour BEVERLY, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V:LXG) (the "Company"), a ... […]
- Five rules to tackle antibiotic resistance on May 15, 2019 at 12:58 am
Current efforts to tackle antibiotic resistance are "not nearly radical enough", a leading scientist says. Dr. Ben Raymond, of the University of Exeter, says relying too heavily on reducing ... […]
via Bing News